"Clear, never condescending, and with abundant references to biotech firms and their work in progress, The Biotech Investors Bible is a book that had to be written. Essential for the investor, fascinating even for armchair students of the industry, its a valuable reference, a guide to what is coming, and an irresistible read . . . it will be a definitive reference in the field."Andrew Allentuck, globetechnology.com
"The Biotech Investors Bible outlines sensibly and with balance the opportunities and challenges of an industry that will change our lives. A must read guide for the individual investor."William A. Haseltine, Ph.D., Chairman, CEO, and Founder, Human Genome Sciences, Inc., Editor-in-chief, E-Biomed: The Journal of Regenerative Medicine
Investors with a practical understanding of biotechnology share a remarkable opportunity: the chance to invest in an industry on the threshold of tremendous growth. With the long-term potential to cure most major diseases and to revolutionize industries as diverse as pharmaceuticals and forestry, petrochemicals and agriculture, the possibilities for biotechand its investorsare limitless.
The Biotech Investors Bible provides you with the strategies and proven techniques to reduce risk and increase returns, including:
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
"Clear, never condescending, and with abundant references to biotech firms and their work in progress, The Biotech Investors Bible is a book that had to be written. Essential for the investor, fascinating even for armchair students of the industry, its a valuable reference, a guide to what is coming, and an irresistible read . . . it will be a definitive reference in the field."Andrew Allentuck, globetechnology.com
"The Biotech Investors Bible outlines sensibly and with balance the opportunities and challenges of an industry that will change our lives. A must read guide for the individual investor."William A. Haseltine, Ph.D., Chairman, CEO, and Founder, Human Genome Sciences, Inc., Editor-in-chief, E-Biomed: The Journal of Regenerative Medicine
Investors with a practical understanding of biotechnology share a remarkable opportunity: the chance to invest in an industry on the threshold of tremendous growth. With the long-term potential to cure most major diseases and to revolutionize industries as diverse as pharmaceuticals and forestry, petrochemicals and agriculture, the possibilities for biotechand its investorsare limitless.
The Biotech Investors Bible provides you with the strategies and proven techniques to reduce risk and increase returns, including:
Imprint | John Wiley & Sons |
Country of origin | United States |
Release date | June 2001 |
Availability | Expected to ship within 12 - 17 working days |
First published | 2001 |
Authors | G. Wolff |
Dimensions | 240 x 161 x 27mm (L x W x T) |
Format | Hardcover |
Pages | 321 |
ISBN-13 | 978-0-471-41279-3 |
Barcode | 9780471412793 |
Categories | |
LSN | 0-471-41279-1 |